Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study

Journal of the Neurological Sciences
Wolfgang H JostJ Wissel

Abstract

The current practice in Germany and Austria, and the safety and efficacy of botulinum toxin type A (BoNT-A; Dysport) in the treatment of patients with post-stroke arm spasticity (with no fixed upper-limb contractures), were assessed in this observational prospective non-interventional study. One treatment cycle was documented with assessments at baseline, approximately week 4 (optional), and approximately week 12. Pattern of spasticity, treatment goal, safety and efficacy were recorded. Overall response and goal achievement was rated on a 4-point scale ('no goal achievement', 'goal achievement', 'good goal achievement', 'best goal achievement'). In total, 409 patients were included and 99% assigned to one of five arm-spasticity patterns. Therapy goals included reduced muscle tone (92.6%), physiotherapy or occupational therapy support (63.8%), increased range of motion (61.8%), pain reduction (58.9%), facilitation of care or hygiene (55.7%), and functional improvement (17.0%). Goals were achieved in 84% of patients. The following factors had the most potential as predictors of treatment outcome: pre-treatment; time since onset of spasticity; pattern of arm spasticity. Mean Dysport dose was 728 U and an inverse dose-response rela...Continue Reading

Associated Clinical Trials

References

Mar 7, 1992·BMJ : British Medical Journal·D T WadeC P Warlow
Apr 23, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R PellizzariC Montecucco
Nov 25, 2000·British Medical Bulletin·B B Bhakta
Jan 11, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A M BakheitL Coxon
May 7, 2008·Neurology·D M SimpsonUNKNOWN Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Feb 7, 2009·Journal of Rehabilitation Medicine·Jörg WisselNiko Tieranta
Feb 16, 2010·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Abdel Magid BakheitJorg Wissel
May 14, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Andy Pickett
May 5, 2012·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Harald HefterJörg Wissel

❮ Previous
Next ❯

Citations

Sep 1, 2015·Lancet Neurology·Jean-Michel GraciesUNKNOWN International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group
Jun 19, 2016·PM & R : the Journal of Injury, Function, and Rehabilitation·Andrew K TreisterEric Y Chang
Jun 8, 2017·Muscle & Nerve·Jean-Michel GraciesUNKNOWN International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group
Jun 22, 2017·PM & R : the Journal of Injury, Function, and Rehabilitation·Michael W O'DellJean Michel Gracies
Mar 29, 2018·Maxillofacial Plastic and Reconstructive Surgery·Hyun SeokJanghoon Ahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.